Graham Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,283
Closed -$4.08M 1368
2025
Q1
$4.08M Buy
40,283
+4,533
+13% +$443K 0.07% 161
2024
Q4
$3.3M Buy
35,750
+1,067
+3% +$105K 0.05% 195
2024
Q3
$3.35M Sell
34,683
-17,460
-33% -$1.57M 0.06% 173
2024
Q2
$4.47M Buy
52,143
+47,749
+1,087% +$4.01M 0.1% 119
2024
Q1
$363K Buy
+4,394
New +$322K 0.01% 716
2023
Q2
Sell
-9,653
Closed -$522K 1045
2023
Q1
$522K Buy
+9,653
New +$562K 0.02% 742
2022
Q3
Sell
-6,655
Closed -$296K 1121
2022
Q2
$296K Buy
6,655
+2,034
+44% +$104K 0.01% 830
2022
Q1
$261K Sell
4,621
-2,823
-38% -$147K 0.01% 768
2021
Q4
$386K Buy
+7,444
New +$384K 0.02% 238

Other funds holding EHC

Graham Capital Management's EHC Position: Q2 2025 in Review

Graham Capital Management sold out of Encompass Health (EHC) in Q2 2025, closing a stake of 40,283 shares — an estimated $4.08M sold.

Graham Capital Management first reported a position in EHC in Q4 2021 and held it in 9 quarters. The position peaked at $4.47M in Q2 2024. 606 funds tracked by Wall St. Rank hold EHC as of Q2 2025.

  • Graham Capital Management reported no remaining Encompass Health position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 40,283 Encompass Health shares in Q2 2025, an estimated $4.08M.
  • Graham Capital Management first reported a position in Encompass Health in Q4 2021 and held it in 9 quarters.
  • Graham Capital Management's Encompass Health position peaked at $4.47M in Q2 2024.
  • 606 funds tracked by Wall St. Rank held Encompass Health as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.